Eli Lilly 2013 Annual Report Download - page 157

Download and view the complete annual report

Please find page 157 of the 2013 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 160

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160

59
Executive Committee
John C. Lechleiter, Ph.D.
Chairman, President, and Chief Executive Ocer
Melissa Stapleton Barnes
Senior Vice President, Enterprise Risk Management, and Chief
Ethics and Compliance Ocer
Enrique A. Conterno
Senior Vice President, and President, Lilly Diabetes
Maria Crowe
President, Manufacturing Operations
Stephen F. Fry
Senior Vice President, Human Resources and Diversity
Michael J. Harrington
Senior Vice President and General Counsel
Jan M. Lundberg, Ph.D.
Executive Vice President, Science and Technology, and
President, Lilly Research Laboratories
Susan Mahony, Ph.D.
Senior Vice President, and President, Lilly Oncology
Barton R. Peterson
Senior Vice President, Corporate Aairs and Communications
Derica W. Rice
Executive Vice President, Global Services, and
Chief Financial Ocer
David A. Ricks
Senior Vice President, and President, Lilly Bio-Medicines
Jeffrey N. Simmons
Senior Vice President, and President, Elanco Animal Health
Fionnuala Walsh, Ph.D.
Senior Vice President, Global Quality
Alfonso G. Zulueta
Senior Vice President, and President, Emerging Markets
Senior Leadership
E. Paul Ahern, Ph.D.
Senior Vice President, Global API and Dry Products
Manufacturing
Alex M. Azar II
President, Lilly USA
Robert B. Brown
Senior Vice President, Marketing, and Chief Marketing Ocer
omas F. Bumol, Ph.D.
Senior Vice President, Biotechnology and Autoimmunity
Research, and President, Applied Molecular Evolution
Timothy J. Garnett, M.D.
Senior Vice President, Development Center of Excellence,
Lilly Research Laboratories, and Chief Medical Ocer
Richard B. Gaynor, M.D.
Senior Vice President, Global Oncology Development and
Medical Aairs
omas W. Grein
Senior Vice President, Finance, and Treasurer
William F. Heath Jr., Ph.D.
Senior Vice President, Product and Clinical: Design,
Development, and Delivery
Andrew Hotchkiss
President, Europe/Australia/Canada Operations
Myles O’Neill
Senior Vice President, Global Parenteral Drug Product and
Delivery Devices Manufacturing
Joshua L. Smiley
Senior Vice President, Finance, and Chief Financial Ocer,
Lilly Research Laboratories
omas R. Verhoeven, Ph.D.
Senior Vice President, Development Center of Excellence,
Lilly Research Laboratories
J. Anthony Ware, M.D.
Senior Vice President, Product Development,
Lilly Bio-Medicines